Africa and STI’s
Transcript
THANDEKA: Le nkongolo ijongene nezifo ezasulelana ngesondo nogawulayo okanye i-ICASA.
Translation:ICASA’s main objective is to unite African scientists in the fight against opportunistic diseases, HIV and the provision of anti AIDS drugs says Dr. Malaki Owili. He says Africans should start sharing information on factors affecting them.
DR OWILI: This conference has been going on since 1990 in African countries its purpose is to unite all the African Scientists and share our experiences and observations on HIV in Africa. The last ICASA meeting was held in Ouagadougou in West Africa and this time this September it will be held in Nairobi it is a very important meeting for the Africans scientists and clinicians working in HIV and we intend to have about 8 000 delegates coming from Africa and Europe to attend this important meeting. So really we are appealing to the African scientists not even scientists but even the community to come forward and listen and share with us our experiences on HIV management. The topic (theme) this time is ‘care and challenges in HIV’.
THANDEKA: Uthi kusekho ingxaki enkulu eAfrika nalapho amachiza okunyanga izifo ezosulelayo ngesondo nogawulayo zingafane zifumaneke nje kuba zibiza kakhulu utsho ebala ii-ARV’s nezizithomalalisi kwintholongwane kagawulayo.Ubongongoza izirhulumente ukuba zingenelele nalapho kufuneka zizame ukunikezela lamachiza.
Translation:DR OWILI: Well, we have a lot of problems here especially in Afrika, first of all challenges in the access to the medicine, access to the drugs that they use in the treatment or the management of HIV and AIDS and also sexually transmitted diseases. Some of the drugs as we know are known as ARV, the anti retroviral drugs are very expensive. An ordinary African cannot afford to get these drugs. So the governments, the African governments have to put their heads together and find out how the people suffering with HIV can have access to the drugs. What I mean about that, I mean reduce the price and find ways or means how these drugs can reach the people. We have also other challenges these are diagnostic challenges how can we really have the diagnostic kits which are cheaper that we can use to first make a diagnosis of the disease and also to monitor the treatment process of this disease. And other challenge are that we would like our politicians to really recognize that AIDS is really appalling and find out in general how we can reduce AIDS in Africa.
THANDEKA:Ndimbuza ukuba ngaba ucinga ukuba iinkokheli zeAfrica ziyamamela xa kuthethwa ngogawulayo yaye zithabatha inxaxheba ekusombuleni ugawulayo. Uthi ewe ziyazama ukuthetha ngalemiba uthi unethemba lokuba imibutho efana ‘Nemanyano yeAfrica’ (African Unity) ingadlala indima enkulu ukulwa imiba efana nogawulayo ngoncedo oluvela kumazwe aseNtshona.
Translation: DR OWILI: Well, I’m sure they are able to do this because there was a meeting in Abuja and in this meeting they discussed about AIDS and I’m sure the organization of Africans if they get together and put HIV/AIDS as one of the very important issues to be discussed we would be able to do that with the help from the West. We will be able to tackle this, it is very important that we get the moral support from our governments because scientists cannot work in isolation they work together with the governments.
E-mail Thandeka Teyise
Author
-
Health-e News is South Africa's dedicated health news service and home to OurHealth citizen journalism. Follow us on Twitter @HealtheNews
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
-
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
-
You must include all of the links from our story, including our newsletter sign up link.
-
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
-
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
-
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
-
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
-
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Africa and STI’s
by healthe, Health-e News
September 18, 2003